Hydroxyurea Capsules used inÂ sickle-celldisease,Â chronic myelogenousleukemia,Â cervical cancer, andÂ essential thrombocythemia.Â In sickle-cell disease it increasesÂ fetalhemoglobinÂ and decreases the number of attacks.
Tags: Hydroxyurea Tabletsmanufacturer ,Gefitinib Tablets exporter, Hydroxyurea Tablets supplier, HydroxyureaÂ Â Tablets,Hydroxyurea Â potassium, whogmp approved Hydroxyureapotassium tablets manufacturer and supplier, Hydroxyurea Â Tablets distributor ,Hydroxyurea Â Tablets drop shipper, Hydroxyurea Tablets 500 mg,Hydroxyurea Tablets 500 mg supplier, Hydroxyurea Â Tablets 500 mg.
ISO/GMP/c-GMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approvedmanufacturing facility in Gujarat, India.
Registration: SaintroyLifescience is interested in registration of own brand or customer brands inministry of health of clientÃ¢ÂÂs country and we also provide the productssamples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free salecertificate and other required documents.
Export Country : SaintroyLifescienceÂ export Hydroxyurea Â Tabletsto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.